Newsroom
Article published in Drug Discovery Today: Learning from European regulator-initiated studies for regulatory decision making
"Future meetings, discussions and workshops within, but not limited to, the European regulatory network are recommended to establish publicly disclosed interaction models to facilitate interaction between stakeholders (...) with the goal of realising an optimal framework for generating RWE to be included in the regulatory decision-making process."
An article based on the discussions and findings from the RSNN Expert Meeting "Regulator-initiated studies for regulatory decision making", which took place in 2022, was published recently in Drug Discovery Today.
Read the full article online here: link